News

BAFNA PHARMACEUTICALS LIMITED will hold its 31st Annual General Meeting on Friday, September 11, 2026, at 10:00 A.M. (IST) through Video Conferencing (VC) / Other Audio-Visual Means (OAVM), with the Register of Members and Share Transfer Books closed from Saturday, September 05, 2026 to Friday, September 11, 2026, and has engaged Central Depository Services (India) Limited (“CDSL”) for providing E-Voting services.

Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 11 August 2026.

Net profit of Bafna Pharmaceuticals rose 109.92% to Rs 2.75 crore in the quarter ended March 2026 as against Rs 1.31 crore during the previous quarter ended March 2025. Sales rose 8.14% to Rs 42.24 crore in the quarter ended March 2026 as against Rs 39.06 crore during the previous quarter ended March 2025.For the full year,net profit rose 167.47% to Rs 11.10 crore in the year ended March 2026 as against Rs 4.15 crore during the previous year ended March 2025. Sales rose 3.26% to Rs 150.62 crore in the year ended March 2026 as against Rs 145.86 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales42.2439.06 8 150.62145.86 3 OPM %8.407.96 -10.587.66 - PBDT4.283.32 29 17.0411.19 52 PBT2.623.10 -15 10.976.30 74 NP2.751.31 110 11.104.15 167 Powered by Capital Market - Live News

Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 May 2026.

Net profit of Bafna Pharmaceuticals rose 93.68% to Rs 1.84 crore in the quarter ended December 2025 as against Rs 0.95 crore during the previous quarter ended December 2024. Sales rose 15.37% to Rs 38.29 crore in the quarter ended December 2025 as against Rs 33.19 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales38.2933.19 15 OPM %7.979.25 - PBDT3.412.62 30 PBT1.840.96 92 NP1.840.95 94 Powered by Capital Market - Live News